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Abstract
Background: Multidrug-resistant (MDR) infections are a serious concern for children admitted to the Paediatric
Intensive Care Unit (PICU). Tracheal colonization with MDR Enterobacteriaceae predisposes to respiratory infection,
but underlying risk factors are poorly understood. This study aims to determine the incidence of children with
suspected infection during mechanical ventilation and analyses risk factors for the finding of MDR Enterobacteriaceae
in tracheal aspirates.
Methods: A retrospective single-centre analysis of Enterobacteriaceae isolates from the lower respiratory tract
of ventilated PICU patients from 2005 to 2014 was performed. Resistance status was determined and clinical
records were reviewed for potential risk factors. A classification and regression tree (CRT) to predict risk
factors for infection with MDR Enterobacteriaceae was employed. The model was validated by simple and
multivariable logistic regression.
Results: One hundred sixty-seven Enterobacteriaceae isolates in 123 children were identified. The most
frequent isolates were Enterobacter spp., Klebsiella spp. and E.coli. Among these, 116 (69%) isolates were
susceptible and 51 (31%) were MDR. In the CRT analysis, antibiotic exposure for ≥ 7 days and presence of
gastrointestinal comorbidity were the most relevant predictors for an MDR isolate. Antibiotic exposure for ≥
7 days was confirmed as a significant risk factor for infection with MDR Enterobacteriaceae by a multivariable
logistic regression model.
Conclusions: This study shows that critically-ill children with tracheal Enterobacteriaceae infection are at risk
of carrying MDR isolates. Prior use of antibiotics for ≥ 7 days significantly increased the risk of finding MDR
organisms in ventilated PICU patients with suspected infection. Our results imply that early identification of
patients at risk, rapid microbiological diagnostics and tailored antibiotic therapy are essential to improve
management of critically ill children infected with Enterobacteriaceae.
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Background
Critically ill children are at high risk for severe health-
care associated infections (HAI) due to invasive devices
and procedures, secondary immunosuppression and
underlying diseases [1–3]. Multidrug-resistant (MDR)
Gram-negative infections are an increasing threat to
children admitted to the Paediatric Intensive Care Unit
(PICU). However, predisposing factors for colonization
and infection with MDR Gram-negative organisms are
unclear in this vulnerable patient population.
MDR Enterobacteriaceae have become a particular
concern for mechanically ventilated patients [4]. Placement
of an endotracheal tube is followed rapidly by tracheal
colonization with potentially pathogenic microorganisms
from the oropharyngeal flora, including MDR organisms
[5, 6]. Colonization of the lower respiratory tract by en-
dogenous flora or opportunistic pathogens provides the
major route to acquiring ventilator-associated pneumonia
(VAP) [7]. Moreover, increased nasopharyngeal bacterial
density is associated with a higher risk of invasive respira-
tory disease [8].
Data characterizing tracheal colonization in mechanic-
ally ventilated children independent of respiratory infec-
tion are scarce and vary substantially among hospitals
and across countries as well as throughout the course of
mechanical ventilation [9]. A clear predominance for
Gram-negative organisms in ventilated PICU patients
has been described in a paediatric colonization study in
India [10]. Furthermore, endotracheal colonization was
dominated by Enterobacteriaceae, in particular E.coli
and Enterobacter, in two recent studies of VAP in adults
and children [4, 11].
However, bacterial colonization does not necessarily
imply infection and tracheal aspirates lack specificity for
VAP [5]. Nevertheless, tracheal aspirates are part of the
Center for Disease Control’s (CDC) criteria for the diag-
nosis of VAP and are frequently used to guide antibiotic
therapy in PICU [12].
Empiric antibiotic treatment of Gram-negative infec-
tions is becoming increasingly difficult, because antibi-
otics that were previously considered the treatment of
choice are no longer useful in MDR Gram-negative organ-
isms [13–15]. If initial antimicrobial therapy is ineffective
and only few treatment options remain in critically ill chil-
dren, recurrence of infection, morbidity, mortality, length
of PICU and hospital stay as well as healthcare costs will
rise [13, 14]. Empiric antibiotic therapy might be improved
by the identification of risk factors for colonization and
infection with Enterobacteriaceae.
Risk factors for the acquisition of Enterobacteriaceae,
especially extended-spectrum ß-lactamase (ESBL) pro-
ducing organisms were investigated in adults during a
stay in the intensive care unit. Major risk factors for in-
fection due to ESBL-producing bacteria were: travel to
high-prevalence countries, prior antibiotic use and
mechanical ventilation [16]. Similar potential risk factors
for infection due to MDR Enterobacteriaceae have been
identified in neonates and children including the pres-
ence of chronic disease, previous hospitalization, inva-
sive ventilation, pre-term low birth weight and antibiotic
intake [17]. In particular, prior use of cephalosporins has
been defined as an independent risk factor for the acqui-
sition of MDR Enterobacteriaceae [18, 19]. Preceding
antibiotic therapy may lead to a disruption of the intes-
tinal flora and facilitate colonization and overgrowth of
nosocomial MDR Gram-negative organisms [20]. These
MDR strains increase the risk of infection by progressive
colonization of the gastrointestinal and subsequently the
respiratory tract during a hospital stay [21].
To our knowledge, clinical risk factors for infection of
mechanically ventilated PICU patients with MDR En-
terobacteriaceae have not been described to date. Know-
ledge of potential clinical risk factors for infection with
MDR Enterobacteriaceae might help to initiate appropri-
ate infection control precautions to prevent transmission
of MDR bacteria in PICU and improve empiric anti-
biotic treatment.
Therefore, we aimed to determine the incidence and
spectrum of MDR Enterobacteriaceae in children with
suspected respiratory tract infection admitted to a large
academic PICU from 2005 to 2014. Additionally, we
analysed risk factors for the finding of MDR Enterobac-
teriaceae in these mechanically ventilated children.
Methods
Patient population and setting
A retrospective, single-centre analysis was performed in
ventilated patients admitted to the PICU of the Univer-
sity Children’s hospital in Tübingen during the period
from 2005 to 2014. This 12-bed PICU cares for critically
ill infants and children with around 860 admissions per
year. The main reason for admission is requiring cardiac
surgery (46%), followed by general paediatric surgery
(28%) and paediatric medical conditions that require in-
tensive care treatment (22%). About 40 patients per year
(5%) are transferred from long-term care facilities and
have chronic conditions that require long-term tracheos-
tomy. The organisational structure of this ward remained
unchanged during the study period. Foreign-born patients
from Eastern Europe and Senegal admitted for surgical
and cardiothoracic procedures are an increasing part of
the patient population in this PICU. Mechanically venti-
lated patients aged below 18 years with a tracheal aspirate
positive for Enterobacteriaceae were identified from the
institution’s Microbiology Database (HyBase Database,
Cymed) and included in the study. Long-term ventilated
children with tracheostomy were excluded. Medical re-
cords of these children were reviewed and demographic,
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clinical and microbiological data were extracted. Data ob-
tained included age, sex, gestational age, birth weight,
weight, height and BMI on admission. As exposures, we
collected the following underlying conditions: pulmonary,
cardiosurgical, neurological, gastroenterological, haema-
tooncological disease and immunodeficiency, ventilated
days before infection, days on ECMO and presence and
days of a central venous line in situ before infection, dur-
ation of catecholamine therapy and days of antibiotic ther-
apy in the 30 days before the positive culture result.
Diagnosis of ventilator-associated pneumonia was made at
the time of the positive tracheal culture result and defined
according to the CDC criteria [12]. Secondary outcomes
after infection were total ventilation days, PICU length of
stay and all-cause mortality after 6 months. Microbio-
logical data included the isolated organism in tracheal
aspirate and a resistogram.
Screening policy and infection control
On our PICU, children admitted from long-term care fa-
cilities, children with previous hospitalization within the
last year or from high-prevalence countries are screened
routinely for bacteria and resistances on admission.
Screening includes a nasal swab for Methicillin-resistant
Staphylococcus aureus (MRSA) since 2004 and a rectal
swab for Vancomycin-resistant Enterococci (VRE) since
2012. During routine patient care, tracheal aspirates
were taken from ventilated patients with clinical findings
suggesting infection (including new onset of fever, rise in
inflammatory markers or decline in oxygenation) or
when tracheal aspirate had a purulent appearance. In
case of isolation of an MDR organism, hygiene measures
were set up according to the guidelines of the German
Commission for Hospital Hygiene and Infectious Disease
Prevention at the Robert Koch Institute and the local
Hospital Hygiene Plan [22]. Isolation in a single room,
contact and droplet precautions were performed to pre-
vent transmission. To promote proper hand hygiene, an
alcohol disinfectant is offered at each patient’s bedside. Pa-
tient to healthcare worker ratio was between 2:1 and 3:1.
Mechanical ventilation
The mechanical ventilation system including humidifica-
tion was set up by a Paediatric Intensive Care Nurse fol-
lowing standard procedures. Ventilatory parameters were
set according to physician’s orders, adjustments were
guided by routinely obtained blood gas analysis. Open or
closed suctioning was performed as clinically indicated.
Analysis of specimens
Specimens were collected through deep suctioning with
the catheter passing beyond the endotracheal tube tip
into the trachea or bronchi. The aspirate was routinely
analysed in our hospital Microbiology Laboratory. Analysis
was performed according to the local guidelines of the hos-
pital Microbiology Laboratory. Organisms from tracheal
aspirates were grown on agar plates or with liquid culture
technique and incubated at 37 °C. Growth of organisms
was monitored according to the local protocol. Susceptibil-
ity testing was realized by disc diffusion technique or the
automated rapid susceptibility test system VITEK 2 (bio-
Mérieux). To identify the organisms, the isolates under-
went MALDI-TOF analysis or biochemical identification
with the automated VITEK 2 system. Clinical breakpoints
recommended by the European Committee On Antimicro-
bial Susceptibility Testing (EUCAST) were used to define
susceptibility and resistance [23].
Definition of infection and MDR
Infection was defined as the recovery of an Enterobacte-
riaceae isolate from the usually sterile respiratory tract.
In this setting it was only possible to use the term “infec-
tion” to refer to both the situation in which infection
was suspected with Enterobacteriaceae recovered from
tracheal aspirate as well as to a respiratory disease (e.g.,
mild inflammation of the airways, tracheitis, ventilator-
associated pneumonia etc.) that was attributed to the
isolated microbe [24]. Resistance status was determined
for each isolate according to the definition proposed by
the European Society of Clinical Microbiology and Infec-
tious Diseases for interim standard definitions for ac-
quired resistance [25]. MDR was defined as acquired non-
susceptibility to at least one agent in three or more anti-
microbial categories with respect to intrinsic resistances.
Statistical methods
To avoid bias due to multiple isolates in one patient, only
the first isolate per patient was included. Patient data were
analyzed using IBM SPSS Statistics Version 22 for Win-
dows. Missing data points or data that were not applicable
to the analysis were excluded. Statistical analysis was per-
formed in consultation with the Department of Statistics/
Biometrics of the University of Tübingen. Categorical vari-
ables between groups were compared with the [chi]2 test.
Means of the two different groups were evaluated by two
sample unpaired t-test if continuous variables were nor-
mally distributed. For intergroup comparison of continu-
ous variables that were not normally distributed, the
nonparametric Mann–Whitney U-Test was used. A p-
value <0.05 was considered statistically significant. Results
are presented as numbers for categorical variables. Nor-
mally and abnormally distributed quantitative variables are
presented as mean ± standard deviation and median (mini-
mum and maximum or interquartile range), respectively.
Analysis of risk factors
Various studies have been performed to study risk fac-
tors for infection with MDR organisms in PICU patients
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[26–28]. Ten candidate risk factors, clinically relevant
for infection with MDR organisms and available to study
in our PICU setting, were selected from the literature
[27–30]. These were patient age, duration of mechanical
ventilation before infection, days of antibiotic pre-
exposure, duration of presence of a central venous line,
duration of catecholamine therapy, pre-existing gastro-
enterological, cardiac and pulmonary disease, length of
PICU stay before culture and days on ECMO. In order to
select suitable predictor variables for a final multivariable
logistic regression model, we undertook a stepwise ap-
proach: First, a classification and regression tree (CRT)
was employed to select the main risk factors for infection
with MDR Enterobacteriaceae. The CRT approach is par-
ticularly applicable to find specific subgroups, relation-
ships and cut-offs of continuous variables in larger sets of
predictor variables that might not be detected with more
common methods, often used in similar analyses (e.g.
multivariable regression equations). These cut-off points
can then be used to transform continuous into categorical
variables for further analysis [31, 32]. Hence, we used CRT
to select the input set of variables and to potentially find
optimal cut-off points for categorisation of continuous
variables in the following analysis. Second, we validated
the findings with the common method of simple logistic
regression, since the CRT model is a relatively uncommon
statistical method. Odds ratio (OR) and 95% confidence
interval (CI) were determined for each of the 12 risk factor
variables. Third, variables found by the CRT model as well
as variables with a p-value of <0.2 in the univariate ana-
lyses were selected as candidates for a multivariable logis-
tic regression model. A stepwise backward selection
process was used. In each step the variable with the least
significant effect was eliminated. A cut-off of αcrit < 0.1
(“p-to-remove”) was set as a limit for removal of variables
from the model. Statistics were all performed using SPSS
(IBM SPSS Statistics Version 22 for Windows). A thor-
ough explanation of the decision tree procedure, the
model criteria and the command file for reproducing the
classification tree are provided as Additional file 1 [33].
Results
From 2011 to 2014, we observed a significant increase in
the incidence of isolated Enterobacteriaceae specimens
in tracheal aspirate compared to the beginning of the
study period from 2005 to 2008 (mean 1.14 ± 0.55 vs
2.78 ± 0.56; p = 0.006). No MDR organisms were isolated
in 2004, but 5 in 2014. However, there was high annual
variability (see Additional file 2).
Spectrum of isolates
During the whole study period, we obtained 167 Entero-
bacteriaceae isolates from the lower respiratory tracts of
123 intubated patients. 116 (69%) isolates were susceptible
and 51 (31%) of all isolates were identified as MDR En-
terobacteriaceae. The spectrum of isolates is shown in
Additional file 3. Enterobacter spp. were the most preva-
lent genera (51 isolates, 30.5%), followed by Escherichia
coli (47 isolates, 28.1%) and Klebsiella spp. (46 isolates,
27.5%). Most MDR organisms were E.coli (26/47 isolates),
followed by Klebsiella spp. (13/46 isolates), Enterobacter
spp. (7/51 isolates) and Morganella (4/6 isolates). The total
number of ESBL producing organisms was 13 (7.8%) of all
isolates. 7 out of 47 (14.9%) E.coli and 3 out of 46 (6.5%)
Klebsiella spp. were ESBL-producing isolates.
Patient characteristics and outcome
Patient characteristics and the clinical outcomes of 123
intubated children with Enterobacteriaceae infection are
shown in Tables 1 and 2. Patients with MDR organisms
did not differ from patients infected with susceptible or-
ganisms in sex, age, percentage of infants, gestational
age, birth weight, BMI, presence and days with CVC in
situ and days of antibiotic exposure during the last
4 weeks prior to the tracheal aspirate. Underlying dis-
eases and conditions were similar between both groups
with the exception of immunodeficiency, which was sig-
nificantly more frequent in patients infected with an
MDR organism. The clinical outcome was similar in
children infected with an MDR versus a susceptible
strain: children infected with Enterobacteriaceae had a
median total ventilation time of 6 [IQR 3–19] and 8
[IQR 2–16] days, respectively. PICU length of stay was
also similar in patients with MDR and susceptible strains
(14 and 14.5 days). VAP occurred in 18 cases, resulting
in a VAP incidence rate of 14%. With 9 VAP cases in
both groups, this results in a VAP incidence rate of 11%
among patients who were infected with a susceptible
Table 1 Characteristics of the source population and study population
Source population (n = 7551) Study population (n = 123)
MDR (n = 43) Susceptible (n = 80) p-value
Characteristics of the source and study population
Sex m/f 4129/3422 24/19 50/30 0.47
Infant/Non-infant 974/6577 25/18 53/27 0.37
Age in years (median, [IQR]) 3.3 [0.5;10.7] 0.4 [0.1;2.5] 0.6 [0.2;2.0] 0.94
Comparison between patients with MDR (n = 43) and susceptible (n = 80) isolates. MDR Multidrug-resistant Enterobacteriaceae, IQR Interquartile Range
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organism. Incidence rate of infection (21%) and all-cause
mortality after 6 months (20%) were almost doubled in
patients infected with MDR organisms. However this
difference did not reach significance (p = 0.15, p = 0.22)
(Tables 1 and 2).
Patient characteristics and clinical outcome
The CRT analysis (Fig. 1) revealed that length of antibiotic
pre-exposure and presence of gastrointestinal comorbidity
were the most relevant predictors for infection with an
MDR strain. In this study, 62% of Enterobacteriaceae iso-
lates were MDR if the duration of antibiotic pre-exposure
was ≥7 days. Furthermore, the analysis revealed gastro-
intestinal comorbidity as a second predictive factor for
MDR: In individuals infected with Enterobacteriaceae and
a short duration of antibiotic exposure (<7 days), isolation
of MDR strains was more likely if gastrointestinal comor-
bidity was present (40%). Conversely, isolation of suscep-
tible strains was most likely in individuals without
gastrointestinal comorbidity and with a short duration of
antibiotic pre-exposure (<7 days) (85%). When evaluating
the entire CRT model with both predictive parameters,
the overall percentage of correct prediction was 71%, the
risk of misclassification was 29%. Classification of suscep-
tible strains was far more accurate (86% classified cor-
rectly) than classification of MDR strains alone (42%
classified correctly). Normalised importance of the factors
revealed days of antibiotic pre-exposure as the most rele-
vant factor for MDR (100%), followed by gastrointestinal
comorbidity (47%) (Additional file 4). These most relevant
factors were included into a multivariable logistic re-
gression analysis for further validation. According to
the results of the CRT, antibiotic exposure was trans-
formed into a categorical variable (antibiotic exposure
for ≥7 days) for logistic regression analysis. Simple lo-
gistic regression analysis revealed antibiotic exposure
for ≥7 days as a significant risk factor for infection
with an MDR organism (OR 4.25; 95% CI 1.62-11.14).
Gastrointestinal comorbidity did not reach signifi-
cance as a potential risk factor for MDR in this ana-
lysis (OR 1.97; 95% CI 0.93–4.18) (Additional file 5).
Variables found by the CRT model and variables with
a p-value of <0.2 in the univariate analyses were se-
lected as candidates for a multivariable logistic regres-
sion model. Candidates included antibiotic exposure
for ≥7 days, gastrointestinal comorbidity and days on
ECMO. After a backward elimination process, anti-
biotic exposure for ≥7 days and gastrointestinal co-
morbidity remained the most important risk factors
for isolation of MDR Enterobacteriaceae. However,
when entered into a multivariable logistic regression
model (Table 3), gastrointestinal comorbidity did not
reach significance as a predictive factor (OR 2.3; 95% CI
0.92–5.77). Antibiotic exposure for ≥7 days remained the
Table 2 Anthropometric data and clinical outcome of the study population
All (n = 123) MDR (n = 43) Susceptible (n = 80) p-value
Gestational age in weeks (median, [IQR]) 37 [34;39] 37 [34;39] 37 [33;39] 0.76
Birth weight (mean ± SD; kg) 2.62 ± 0.93 2.52 ± 1.05 2.67 ± 0.87 0.49
BMI (mean ± SD; kg/m2) 14.02 ± 4.21 13.65 ± 4.62 14.25 ± 3.95 0.47
Underlying diseases or conditions, n (%)
Pulmonary 65 (53) 25 (58) 40 (50) 0.39
Cardiosurgical 80 (65) 27 (63) 53 (66) 0.70
Neurological 60 (50) 20 (47) 42 (53) 0.53
Gastroenterological 61 (50) 26 (61) 35 (44) 0.08
Hematooncological 10 (8) 3 (7) 7 (9) 0.73
Immunodeficiency 4 (3) 4 (9) 0 (0) 0.006
CVC in place, n (%) 62 (66) 24 (55) 38 (48) 0.48
CVC days (median, [IQR]) 2.5 [0;8] 3 [0;9] 2 [0;7] 0.36
Days of antibiotic pre-exposurea (median, [IQR]) 2 [0;7] 4 [0;9] 2 [0;5] 0.2
Ventilated days (median, [IQR]) 7 [3;18] 6 [3;19] 8 [2;16] 0.91
PICU length of stay (median, [IQR]) 14 [7;32] 14 [6;32] 14.5 [7;33] 0.89
VAP Incidence, n (%) 18 (15) 9 (21) 9 (11) 0.15
All-cause mortality, 6 months, n (%) 17 (14) 8 (20) 9 (11) 0.22
Anthropometric data and clinical outcome of the study population of 123 intubated children with Enterobacteriaceae in tracheal aspirates. Comparison between
patients with MDR (n = 43) and susceptible (n = 80) isolates. MDR Multidrug-resistant Enterobacteriaceae, PICU Paediatric Intensive Care Unit, IQR Interquartile
Range, BMI body mass index, CVC central venous catheter, VAP ventilator-associated pneumonia
aDuration of antibiotic therapy up to 4 weeks prior to culture in days
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only significant factor predicting MDR status in infected
patients (OR 4.56; 95% CI 1.69–12.30).
Discussion
In this study we analysed the spectrum of Enterobacteri-
aceae in tracheal aspirates of intubated PICU patients
from 2005 to 2014. The spectrum of Enterobacteriaceae
in lower respiratory tract material revealed Enterobacter
spp., E.coli and Klebsiella spp. as the most common iso-
lates (86%). Comparable data of matching study settings
are scarce in the current literature. Wilson et al. [5] col-
lected daily tracheal aspirates from intubated children.
Consistent with our findings, the most common Gram-
negative organisms isolated were Klebsiella spp. and
E.coli, followed by Citrobacter freundii and Enterobacter
cloacae. Lee et al. [34] described the microbiological
spectrum and susceptibility pattern of clinical isolates
from a PICU and found a rate of 20% ESBL-positive
Klebsiella in 2005. Our study displayed a lower rate with
only 6.5% of Klebsiella spp. isolates being ESBL-positive.
However, more than half of E.coli isolates (55%), about a
quarter of all Klebsiella spp. (28%) isolates and 4 out of
6 Morganella (67%) isolates were MDR in the present
study (Additional file 3). This finding is consistent with
two large, nationwide studies of antibiotic drug use and
bacterial resistance in the United States and in 53
German ICUs [35, 36]. In the latter, the most striking
result was the ten-fold increase of 3rd generation
cephalosporin-resistant E.coli from 2001 to 2008. Highly
resistant E.coli are known to have a 30% increase in in-
fection rate and a higher mortality compared to suscep-
tible isolates [37]. Keeping this in mind, MDR E.coli
should alert PICUs to the prevalence of MDR E.coli.
In total, 167 Enterobacteriaceae isolates from lower re-
spiratory tract samples were identified in 123 ventilated
PICU patients. 43 (35%) patients were infected with MDR
Enterobacteriaceae. Patient characteristics, including the
proportion who were infants, days of antibiotic pre-
exposure, presence of a CVC and underlying diseases did
not differ between patients infected with susceptible ver-
sus MDR organisms. The only exception were patients
with immunodeficiencies, who were significantly more
likely to be infected with an MDR organism.
Clinical outcome of infection with MDR and suscep-
tible Enterobacteriaceae was investigated in this study.
Infection with MDR Gram-negative organisms has been
associated with longer length of hospital stay or length
of PICU stay [38]. We investigated whether patients in-
fected with MDR organisms had more ventilated days in
total, a longer length of PICU stay, a higher incidence of
VAP or a higher all-cause mortality. Clinical outcome
was similar in both groups in our study. This finding is
to be expected, since MDR organisms commonly do not
feature higher pathogenicity than their more susceptible
counterparts of the same genera [39]. However, mortal-
ity from infection with MDR organisms is known to be
higher due to the delay and a lower rate of appropriate
empiric treatment [37, 40]. In our institution, suscepti-
bility testing is rapidly available and empiric antibiotic
therapy is rather aggressive. Differences in outcome may
hardly be detectable in our study based on a low number
of cases and the fact that PICU patients have several other
underlying factors which may influence ventilated days,
length of PICU stay, incidence of VAP and mortality.
Knowledge of potential clinical risk factors for infection
with MDR organisms might help to improve infection
control precautions, diagnostics and empiric antibiotic
therapy. We investigated several factors described in the
literature that could potentially increase the risk of infec-
tion with MDR Enterobacteriaceae [41, 42]. Of these po-
tential risk factors, two were identified by the decision and
regression tree analysis as the most important: (i) the
duration of antibiotic exposure and (ii) gastrointestinal
comorbidity were most relevant for infection with MDR
Enterobacteriaceae.











Antibiotic exposure < 7 days Antbiotic exposure 7 days
Gastrointestinal No gastrointestinal
comorbidity                                     comorbidity
Fig. 1 Classification and regression tree model to predict colonization
with MDR Enterobacteriaceae. GI comorbidity = Gastrointestinal
comorbidities including ileus, inborn abdominal anomalies,
hepatopathies, necrotizing enterocolitis, gastritis and gastroenteritis
Table 3 Multivariable logistic regression model predicting
MDR status in infected patients. Estimates greater than 1 are





Gastrointestinal comorbidity 2.3 0.92–5.77 0.08
Antibiotic pre-exposure ≥7 days 4.56 1.69–12.30 0.003
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Following the tree-based structure of the CRT analysis,
antibiotic pre-treatment for ≥ 7 days increased the risk of
infection with an MDR isolate to 60%. Furthermore,
gastrointestinal comorbidity increased the chance of
MDR infection from 25 to 40% in patients with a short
(<7 days) duration of antibiotic therapy. It is well known
that the stomach represents a reservoir for Gram-negative
bacilli, especially in critically ill children who are fed by
nasogastric tubes or treated with H (2) antagonists [43].
Transmission of pathogens to the lower respiratory tract
may be facilitated in ventilated children with gastrointes-
tinal comorbidities due to a higher rate of contamination
of the hands or apparel of healthcare workers, contami-
nated respiratory equipment and micro-aspiration of
stomach contents and flora into the lower respiratory
tract. Long-term antibiotic use in these children (espe-
cially with cephalosporins) increases selective pressure on
Gram-negative bacilli of the gastrointestinal and oropha-
ryngeal flora, resulting in a higher rate of MDR Enterobac-
teriaceae [28].
Multivariable logistic regression supported the findings
obtained in the CRT model with slight differences. Com-
pared to the tree-based model, the adjusted odds ratio
for gastrointestinal comorbidity did not reach significance.
However, antibiotic exposure for ≥ 7 days remained the
most relevant prognostic factors for infection with MDR
Enterobacteriaceae. The OR of 4.56 (95% CI 1.69–12.30)
for antibiotic exposure for ≥ 7 days indicates that after
antibiotic therapy of 7 days or more, the risk of infection
with MDR Enterobacteriaceae increases 4.56 times for
every additional day of treatment. Our finding is consist-
ent with numerous papers that have demonstrated anti-
biotic exposure as a strong risk factor for infection with
MDR organisms [6, 18, 44]. Furthermore, this study inves-
tigated another important issue: namely, at which particu-
lar time an antibiotic might select MDR organisms in
ventilated PICU patients. Our CRT analysis revealed a
critical cut-off at 7 days of prior antibiotic treatment to in-
crease the risk of infection with MDR Enterobacteriaceae.
This cut-off at 7 days of antibiotic pre-treatment was vali-
dated by multiple logistic regression. In a previous study,
children received antibiotics for clinician-suspected
Ventilator-Associated Tracheitis (VAT) and the cut-off at
7 days of antibiotic therapy discriminated between short-
and prolonged-course therapy, similar to our study. The
hazard of colonization or infection with an MDR organ-
ism was more than 4 times greater if children had received
a prolonged-course of antibiotic treatment, whereas short-
course therapy had a significantly lower incidence of
MDR infection and did not affect clinical outcome [45].
The present study has several limitations. First, this
study was conducted in a retrospective observational
manner and comprised a single PICU in a University
Children’s Hospital. Therefore, data may be of limited
applicability for PICUs in different settings. Second, as-
sessment of risk factors for infection with MDR Entero-
bacteriaceae may have methodological deficits and may
be biased with regards to estimates and associations. Se-
lection bias towards infants and sicker patients may have
affected our results. It is possible that tracheal aspirates
were more likely to be taken in infants who were venti-
lated for a longer time after surgery for congenital heart
or gastrointestinal defects. Consequently, infants might be
overrepresented in our study. Additionally, sicker patients
might have been more likely to be infected with an MDR
pathogen. Furthermore, we could not exclude that the as-
sociation of potential risk factors and infection with MDR
Enterobacteriaceae was influenced by confounding factors.
The patient population investigated in this study is a
highly heterogeneous group with many potential con-
founders that are not uniform. Multiple hospitalisations,
chronic diseases, congenital malformations, medication
like H (2) blockers and antibiotic prophylaxis (e.g. with
cephalosporins) may influence the rate of infection with
MDR organisms. In particular, it is likely that severely
ill children were treated with longer courses and a
broader spectrum of antibiotics. These children may
have a higher risk for infection with MDR organisms.
Third, since there was no active screening policy for
Enterobacteriaceae in tracheal aspirate on our ward,
only patients with suspected infection were included into
the study. Lastly, it should be noted, that the baseline classi-
fication odd (MDR versus susceptible organism) was 50%.
Consequently, an overall predictive value of 71% of the
CRT model implies a 21% increase in predictive accuracy.
Conclusions
In summary, this study shows that Enterobacter spp.,
Klebsiella spp. and particularly E.coli are frequently iso-
lated Enterobacteriaceae in lower respiratory tract mate-
rials in ventilated PICU patients. Gastrointestinal
comorbidity may lead to a higher risk of infection with
MDR isolates in these critically ill children. We demon-
strate that prior use of antibiotics for ≥ 7 days signifi-
cantly increases the risk of selection for MDR isolates in
ventilated PICU patients infected with Enterobacteriaceae.
Collectively, our results imply that early identification of pa-
tients at risk, rapid microbiological diagnostics and tailored
antibiotic therapy are essential to improve management of
critically ill children infected with Enterobacteriaceae.
Additional files
Additional file 1: CRT explanation model criteria and command file.
(DOCX 22 kb)
Additional file 2: Enterobacteriaceae isolates from 2005 to 2014.
(DOCX 16 kb)
Renk et al. BMC Infectious Diseases  (2017) 17:163 Page 7 of 9
Additional file 3: Enterobacteriaceae distribution. Distribution of
Enterobacteriaceae isolates (n = 167) in lower respiratory tract material,
MDR (n = 51) vs susceptible (n = 116) organisms during the study
period. (XLSX 14 kb)
Additional file 4: Risk estimate and classification model. (DOCX 14 kb)
Additional file 5: Simple logistic regression. (DOCX 12 kb)
Abbreviations
BMI: Body mass index; CDC: Centers for Disease Control and Prevention;
CRT: Classification and regression tree; ECMO: Extracorporeal membrane
oxygenation; ESBL: Extended spectrum ß-lactamases; EUCAST: European
Committee On Antimicrobial Susceptibility Testing; HAI: Hospital acquired
infection; ICU: Intensive Care Unit; IQR: Interquartile range; MDR: Multidrug-
resistant; OR: Odds ratio; PICU: Paediatric Intensive Care Unit; VAP: Ventilator-
associated pneumonia; VAT: Ventilator-Associated Tracheitis
Acknowledgments
We thank Dr. Gunnar Blumenstock for his skillful assistance with statistical analysis.
The authors acknowledge support by Deutsche Forschungsgemeinschaft and
OpenAccess Publishing Fund of University of Tübingen.
Funding
This work did not receive any funding. In particular, there was no funding
from any of the following organizations: National Institutes of Health (NIH);
Wellcome Trust; Howard Hughes Medical Institute (HHMI).
Availability of data and materials
Data supporting the findings of this article can be found in Additional
files 1, 2, 3, 4 and 5.
Authors’ contributions
HR drafted the study plan, managed the conduction of the study, assessed
the results scientifically and wrote the manuscript. LS and FN gathered the
data and conducted the study. FH gave microbiological advice and was
involved in microbiological analysis. MK, MH and DH gave advice in planning
and conducting the study and contributed to improve the manuscript. All
authors have intellectually contributed to this article. All authors have read
and approved the final manuscript. This manuscript has not been previously
published nor being considered for publication elsewhere.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study is a secondary analyses of suitably anonymised datasets that did
not require ethics committee review.
Author details
1Dept. of Paediatric Cardiology, Pulmology and Intensive Care Medicine,
University Children’s Hospital Tübingen, Hoppe-Seyler Str. 1, Tübingen 72076,
Germany. 2Institute of Medical Microbiology and Hygiene, University of
Tübingen, Elfriede-Aulhorn-Str.6, Tübingen 72076, Germany. 3Dept. of
Paediatrics, Pediatric Infectious Diseases, Immunology & Pneumology/Cystic
fibrosis, University Children’s Hospital Tübingen, Hoppe-Seyler Str. 1,
Tübingen 72076, Germany.
Received: 12 May 2016 Accepted: 7 February 2017
References
1. Turcotte RF, Brozovich A, Corda R, Demmer RT, Biagas KV, Mangino D, Covington
L, Ferris A, Thumm B, Bacha E, et al. Health care-associated infections in children
after cardiac surgery. Pediatr Cardiol. 2014;35(8):1448–55.
2. de Mello MJ, de Albuquerque MF, Lacerda HR, Barbosa MT, de Alencar
Ximenes RA. Risk factors for healthcare-associated infection in a pediatric
intensive care unit. Pediatr Crit Care Med. 2010;11(2):246–52.
3. Yogaraj JS, Elward AM, Fraser VJ. Rate, risk factors, and outcomes of
nosocomial primary bloodstream infection in pediatric intensive care unit
patients. Pediatrics. 2002;110(3):481–5.
4. Fihman V, Messika J, Hajage D, Tournier V, Gaudry S, Magdoud F, Barnaud G,
Billard-Pomares T, Branger C, Dreyfuss D, et al. Five-year trends for
ventilator-associated pneumonia: Correlation between microbiological
findings and antimicrobial drug consumption. Int J Antimicrob Agents.
2015;46(5):518–25.
5. Willson DF, Conaway M, Kelly R, Hendley JO. The lack of specificity of
tracheal aspirates in the diagnosis of pulmonary infection in intubated
children. Pediatr Crit Care Med. 2014;15(4):299–305.
6. Papakonstantinou I, Angelopoulos E, Baraboutis I, Perivolioti E, Parisi M,
Psaroudaki Z, Kampisiouli E, Argyropoulou A, Nanas S, Routsi C. Risk factors
for tracheobronchial acquisition of resistant Gram-negative bacterial
pathogens in mechanically ventilated ICU patients. J Chemother (Florence,
Italy). 2015;27(5):283–9.
7. Aly H, Badawy M, El-Kholy A, Nabil R, Mohamed A. Randomized, controlled
trial on tracheal colonization of ventilated infants: can gravity prevent
ventilator-associated pneumonia? Pediatrics. 2008;122(4):770–4.
8. Vu HT, Yoshida LM, Suzuki M, Nguyen HA, Nguyen CD, Nguyen AT, Oishi K,
Yamamoto T, Watanabe K, Vu TD. Association between nasopharyngeal
load of Streptococcus pneumoniae, viral coinfection, and radiologically
confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;
30(1):11–8.
9. Carvalho CE, Berezin EN, Pistelli IP, Mimica L, Cardoso MR. Sequential
microbiological monitoring of tracheal aspirates in intubated patients
admitted to a pediatric intensive care unit. J Pediatr. 2005;81(1):29–33.
10. Patra PK, Jayashree M, Singhi S, Ray P, Saxena AK. Nosocomial pneumonia
in a pediatric intensive care unit. Indian Pediatr. 2007;44(7):511–8.
11. Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR. A
prospective study of ventilator-associated pneumonia in children. Pediatrics.
2009;123(4):1108–15.
12. CDC. Device-associated Module PNEU/VAP Pneumonia (ventilator-
associated [VAP] and non-ventilator-associated pneumonia [PNEU]). www.
cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf. Accessed 14 Feb 2017.
13. Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for
treatment of infections with gram-negative bacteria. Clin Microbiol Rev.
2012;25(3):450–70.
14. Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae,
Pseudomonas and Acinetobacter. Trends Microbiol. 2006;14(9):413–20.
15. Hsu AJ, Tamma PD. Treatment of multidrug-resistant gram-negative
infections in children. Clin Infect Dis. 2014;58(10):1439–48.
16. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B,
Weber R. Risks factors for infections with extended-spectrum beta-
lactamase-producing Escherichia coli and Klebsiella pneumoniae at a
tertiary care university hospital in Switzerland. Infection. 2010;38(1):33–40.
17. Dias A, Oliveira G, Oliveira H, Marques M, Rodrigues F. Extended-spectrum
beta-lactamase producing bacilli in a paediatric hospital. Acta Medica Port.
2011;24 Suppl 2:197–206.
18. Huang Y, Zhuang S, Du M. Risk factors of nosocomial infection with
extended-spectrum beta-lactamase-producing bacteria in a neonatal
intensive care unit in China. Infection. 2007;35(5):339–45.
19. Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N. Epidemiology
of infections caused by extended-spectrum beta-lactamase-producing
Escherichia coli and Klebsiella spp.: a nested case–control study from a tertiary
hospital in London. J Hosp Infect. 2006;64(2):115–23.
20. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND,
van den Brink MR, Kamboj M, et al. Vancomycin-resistant Enterococcus
domination of intestinal microbiota is enabled by antibiotic treatment in
mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;
120(12):4332–41.
21. Guentzel M. Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and
Proteus. In: Bellur S, editor. Medical microbiology. 4th ed. Galveston:
University of Texas Medical Branch at Galveston; 1996.
22. Commission for hospital hygiene and infection prevention RKI.
Hygienemaßnahmen bei Infektionen oder Besiedlung mit
multiresistenten gramnegativen Stäbchen. Bundesgesundheitsblatt.
2012;10(55):1311–54.
23. EUCAST. Website of the European Committee On Antimicrobial
Susceptibility Testing. http://www.eucast.org/clinical_breakpoints/.
Accessed 14 Feb 2017.
Renk et al. BMC Infectious Diseases  (2017) 17:163 Page 8 of 9
24. Pirofski L-A, Casadevall A. The meaning of microbial exposure, infection,
colonisation, and disease in clinical practice. Lancet Infect Dis. 2002;2(10):
628–35.
25. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG,
Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-
resistant, extensively drug-resistant and pandrug-resistant bacteria: an
international expert proposal for interim standard definitions for acquired
resistance. Clin Microbiol Infect. 2012;18(3):268–81.
26. Toltzis P, Hoyen C, Spinner-Block S, Salvator AE, Rice LB. Factors that predict
preexisting colonization with antibiotic-resistant gram-negative bacilli in patients
admitted to a pediatric intensive care unit. Pediatrics. 1999;103(4 Pt 1):719–23.
27. Foglia EE, Fraser VJ, Elward AM. Effect of nosocomial infections due to antibiotic-
resistant organisms on length of stay and mortality in the pediatric intensive
care unit. Infect Control Hosp Epidemiol. 2007;28(3):299–306.
28. Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum β-lactamase–producing
Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis. 2015;
60:1389–97.
29. Meltzer LA, McAuley JB, Kumar R, Mary H, Robert W, Logan LK, CDC
Prevention Epicenter Program. A multicenter study of extended spectrum
beta-lactamase producing Enterobacteriaceae infections in children. In: ID
week 2012. San Diego: Room: SDCC Poster Hall F-H; 2012.
30. Levy SS, Mello MJ, Gusmao-Filho FA, Correia JB. Colonisation by extended-
spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive
care unit. J Hosp Infect. 2010;76(1):66–9.
31. Sauerbrei WF. Statistische Modellbildung und Bewertung von Einflußfaktoren in
klinischen und epidemiologischen Studien. Habilitiationsschrift zur Erlangung
der venia legendi für das Fach Medizinische Biometrie. Freiburg im Breisgau:
Albert-Ludwigs-Universität; 2001.
32. Rao V. Introduction to Classification & Regression Trees (CART). http://www.
datasciencecentral.com/profiles/blogs/introduction-to-classification-
regression-trees-cart. Accessed 14 Feb 2017.
33. IBM C. IBM SPSS Decision Trees 21. http://www.sussex.ac.uk/its/pdfs/SPSS_
Decision_Trees_21.pdf. Accessed 14 Feb 2017.
34. Lee CY, Chen PY, Huang FL, Lin CF. Microbiologic spectrum and
susceptibility pattern of clinical isolates from the pediatric intensive care
unit in a single medical center - 6 years’ experience. J Microbiol Immunol
Infect. 2009;42(2):160–5.
35. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of
third-generation cephalosporin-resistant E. coli in German intensive care
units: secular trends in antibiotic drug use and bacterial resistance, 2001 to
2008. Crit care (London, England). 2010;14(3):R113.
36. Logan LK, Braykov NP, Weinstein RA, Laxminarayan R. Extended-spectrum
beta-lactamase-producing and third-generation cephalosporin-resistant
Enterobacteriaceae in children: trends in the United States, 1999–2011.
J Pediatr Infect Dis Soc. 2014;3(4):320–8.
37. Hübner NO. Hygienemaßnahmen bei Infektionen oder Besiedlung mit
multiresistenten gramnegativen bakteriellen Erregern, slides 18–20. https://
www.rki.de/DE/Content/Infekt/Krankenhaushygiene/Kommission/
Ergaenzende_Informationen/MRGN_Vortrag.pdf?__blob=publicationFile.
Accessed 15 Feb 2017.
38. Cosgrove SE. The relationship between antimicrobial resistance and patient
outcomes: mortality, length of hospital stay, and health care costs. Clin
Infect Dis. 2006;42 Suppl 2:S82–89.
39. Marra AR, Wey SB, Castelo A, Gales AC, Cal RG, Filho JR, Edmond MB, Pereira
CA. Nosocomial bloodstream infections caused by Klebsiella pneumoniae:
impact of extended-spectrum beta-lactamase (ESBL) production on clinical
outcome in a hospital with high ESBL prevalence. BMC Infect Dis. 2006;6:24.
40. Figueiredo Costa S. Impact of antimicrobial resistance on the treatment and
outcome of patients with sepsis. Shock (Augusta, Ga). 2008;30 Suppl 1:23–9.
41. Deptula A, Trejnowska E, Ozorowski T, Hryniewicz W. Risk factors for
healthcare-associated infection in light of two years of experience with the
ECDC point prevalence survey of healthcare-associated infection and
antimicrobial use in Poland. J Hosp Infect. 2015;90(4):310–5.
42. Logan LK, Meltzer LA, McAuley JB, Hayden MK, Beck T, Braykov NP,
Laxminarayan R, Weinstein RA. Extended-spectrum beta-lactamase-
producing Enterobacteriaceae infections in children: a two-center case-
case–control study of risk factors and outcomes in Chicago, Illinois. J Pediatr
Infect Dis Soc. 2014;3(4):312–9.
43. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated
pneumonia: its relevance to developing effective strategies for prevention.
Respir Care. 2005;50(6):725–39. discussion 739–741.
44. Kuster SP, Rudnick W, Shigayeva A, Green K, Baqi M, Gold WL, Lovinsky R,
Muller MP, Powis JE, Rau N, et al. Previous antibiotic exposure and
antimicrobial resistance in invasive pneumococcal disease: results from
prospective surveillance. Clin Infect Dis. 2014;59(7):944–52.
45. Tamma PD, Turnbull AE, Milstone AM, Lehmann CU, Sydnor ER, Cosgrove
SE. Ventilator-associated tracheitis in children: does antibiotic duration
matter? Clin Infect Dis. 2011;52(11):1324–31.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Renk et al. BMC Infectious Diseases  (2017) 17:163 Page 9 of 9
